Raptakos Brett Test Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-01-2025
- Paid Up Capital ₹ 0.98 M
as on 06-01-2025
- Company Age 44 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 06-01-2025
- Revenue -1.34%
(FY 2022)
- Profit -53.69%
(FY 2022)
- Ebitda -7.07%
(FY 2022)
- Net Worth 4.08%
(FY 2022)
- Total Assets -0.42%
(FY 2022)
About Raptakos Brett Test Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.98 M.
The company currently has active open charges totaling ₹1.00 M.
Indra Durlabhji, Suhrud Jhaveri, and Ashok Bhave serve as directors at the Company.
- CIN/LLPIN
U24200MH1980PLC023051
- Company No.
023051
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Sep 1980
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Raptakos Brett Test Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Indra Durlabhji  | Director | 09-Sep-1996 | Current |
| Suhrud Jhaveri | Director | 09-Sep-1996 | Current |
| Ashok Bhave | Director | 21-Mar-2006 | Current |
Financial Performance of Raptakos Brett Test Laboratories.
Raptakos Brett Test Laboratories Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.34% decrease. The company also saw a substantial fall in profitability, with a 53.69% decrease in profit. The company's net worth moved up by a moderate rise of 4.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raptakos Brett Test Laboratories?
In 2021, Raptakos Brett Test Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raptakos Brett And Company LimitedActive 94 years 8 monthsIndra Durlabhji, Suhrud Jhaveri and 1 more are mutual person
- Raptakos Lab Private LimitedActive 5 years 3 months
Suhrud Jhaveri and Ashok Bhave are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 12 Sep 1990 | ₹0.50 M | Open |
Bank Of Baroda Creation Date: 23 Mar 1982 | ₹0.50 M | Open |
How Many Employees Work at Raptakos Brett Test Laboratories?
Unlock and access historical data on people associated with Raptakos Brett Test Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raptakos Brett Test Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raptakos Brett Test Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
